Rentschler Biopharma

Rentschler Biopharma is a global leading contract development and manufacturing organization(CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, as well as related consulting activities, project management and regulatory support. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies Densure product quality and productivity at each development and manufacturing step. Rentschler Biopharma is a family-owned company with about 1,400 employees, headquartered in Laupheim, Germany, with operations in Milford, MA, USA. In 2024, the company joined the United Nations Global Compact, emphasizing Rentschler Biopharma’s focus on sustainability.

Key Products and Services

• Biopharmaceutical development
• cGMP manufacturing
• Analytical services
• Process and formulation development services
• Regulatory consulting and client program management
• Xpert Alliance (specialised development solutions)

Rentschler Biopharma’s long-standing commitment to quality and innovation positions it as a trusted partner for biopharmaceutical companies worldwide, empowering the development of life-saving therapies.